These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38296900)

  • 1. Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling Pathway.
    Petralla S; Saveleva L; Kanninen KM; Oster JS; Panayotova M; Fricker G; Puris E
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38296900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Expression of Amino Acid Transporters Is Altered in Isolated Cerebral Microvessels of 5xFAD Mouse Model of Alzheimer's Disease.
    Puris E; Saveleva L; de Sousa Maciel I; Kanninen KM; Auriola S; Fricker G
    Mol Neurobiol; 2023 Feb; 60(2):732-748. PubMed ID: 36367657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals.
    Tacchini L; Gammella E; De Ponti C; Recalcati S; Cairo G
    J Biol Chem; 2008 Jul; 283(30):20674-86. PubMed ID: 18519569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.
    López-Gambero AJ; Rosell-Valle C; Medina-Vera D; Navarro JA; Vargas A; Rivera P; Sanjuan C; Rodríguez de Fonseca F; Suárez J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFR1 knockdown alleviates iron overload and mitochondrial dysfunction during neural differentiation of Alzheimer's disease-derived induced pluripotent stem cells by interacting with GSK3B.
    Kang T; Han Z; Zhu L; Cao B
    Eur J Med Res; 2024 Feb; 29(1):101. PubMed ID: 38321571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.
    Puris E; Saveleva L; Auriola S; Gynther M; Kanninen KM; Fricker G
    Front Pharmacol; 2024; 15():1365051. PubMed ID: 38572427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer's disease.
    Jung Y; Lopez-Benitez J; Tognoni CM; Carreras I; Dedeoglu A
    Brain Res; 2023 Jan; 1799():148171. PubMed ID: 36410428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Every-other-day feeding exacerbates inflammation and neuronal deficits in 5XFAD mouse model of Alzheimer's disease.
    Lazic D; Tesic V; Jovanovic M; Brkic M; Milanovic D; Zlokovic BV; Kanazir S; Perovic M
    Neurobiol Dis; 2020 Mar; 136():104745. PubMed ID: 31931140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of Alzheimer's brain pathology in 5XFAD mice by PTH
    Chen L; Xiong L; Yao L; Pan J; Arzola E; Zhu X; Mei L; Xiong WC
    Alzheimers Res Ther; 2023 Mar; 15(1):53. PubMed ID: 36918976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
    Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
    Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer's disease animal model by regulating immunity.
    Yang X; Ye T; He Y; Wen L; Cheng X
    Front Neurol; 2023; 14():1183764. PubMed ID: 37441611
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Cheng L; Zhang W
    Exp Ther Med; 2021 Jun; 21(6):557. PubMed ID: 33850529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
    Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased central auditory gain in 5xFAD Alzheimer's disease mice as an early biomarker candidate for Alzheimer's disease diagnosis.
    Na D; Zhang J; Beaulac HJ; Piekna-Przybylska D; Nicklas PR; Kiernan AE; White PM
    Front Neurosci; 2023; 17():1106570. PubMed ID: 37304021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.